The GLP-1 Side Effect Nobody's Tracking (But 2026 Research Says You Should)

Everyone on semaglutide or tirzepatide is tracking weight loss. They're monitoring A1C. They're watching their waistline shrink.

But almost nobody is checking their bone density.

New research from the 2026 American Academy of Orthopaedic Surgeons meeting analyzed 73,483 people on GLP-1 drugs over five years. Here's what they found:

GLP-1 users had:

• 29% higher risk of osteoporosis
• 12% higher risk of gout
• 155% higher risk of osteomalacia (soft bones from vitamin D deficiency)

All statistically significant. All compared to matched controls who weren't on GLP-1s.

This doesn't mean GLP-1s are dangerous. The cardiovascular benefits are real. 40% reduction in heart failure risk, fewer heart attacks, longer lives. But if you're on these drugs long-term, your bones deserve attention.

Here's what we know, what's still unclear, and what you should actually do about it.

The Numbers That Matter

The AAOS study tracked patients with obesity or type 2 diabetes who started GLP-1 drugs between 2019 and 2024. They matched them with similar patients not on GLP-1s and watched what happened over five years.

Osteoporosis:

• GLP-1 users: 4.1% developed osteoporosis
• Controls: 3.2%
• Risk increase: 29% (relative risk 1.29, p<0.001)

Gout:

• GLP-1 users: 7.4% developed gout
• Controls: 6.6%
• Risk increase: 12% (relative risk 1.12, p<0.001)

Osteomalacia:

• GLP-1 users: 2.0% developed osteomalacia
• Controls: 0.1%
• Risk increase: 155% (relative risk 2.55, p<0.001)

The absolute numbers are small. Out of 1,000 people on GLP-1s for five years, you'd expect 9 more osteoporosis cases, 8 more gout cases, and 19 more osteomalacia cases compared to people not on the drugs.

But these aren't rare conditions. Osteoporosis affects 10 million Americans. If GLP-1s are adding to that number, it's worth knowing.

Why Is This Happening?

The honest answer: we don't fully know yet.

Theory 1: It's the weight loss, not the drug

When you lose weight fast. whether through calorie restriction, bariatric surgery, or GLP-1s. you lose bone density. Your skeleton was supporting a 250-pound body. Now it's supporting 180 pounds. Less mechanical load means your bones adapt by reducing density.

Studies on calorie restriction and bariatric surgery show similar bone density drops. Weight loss triggers increased bone remodeling. more breakdown, less rebuilding.

Theory 2: It's a direct GLP-1 receptor effect

GLP-1 receptors exist on bone cells. When you activate them with semaglutide or tirzepatide, you might be changing how bones build and break down.

Animal studies are mixed. Some show GLP-1 drugs improve bone density by boosting osteoblasts (bone-building cells) and blocking osteoclasts (bone-breakdown cells). Others show increased bone resorption.

In diabetic rats, GLP-1 drugs improved bone microstructure and increased the OPG/RANKL ratio. a marker of bone formation over breakdown. But in human trials, two studies found either modest bone density loss or no change.

Theory 3: It's nutrient absorption

GLP-1s slow gastric emptying. Food sits in your stomach longer. That might reduce absorption of calcium and vitamin D. two nutrients essential for bone health.

If you're eating less (because GLP-1s suppress appetite), you're also getting less calcium and vitamin D from food. Combine that with reduced absorption, and you've got a bone health problem.

The gout finding is interesting. GLP-1s lower uric acid in most studies. But if rapid weight loss triggers uric acid spikes (which happens during fasting or extreme calorie restriction), that could explain the 12% gout increase.

The osteomalacia spike (155% higher risk) points directly at vitamin D deficiency. Osteomalacia is soft, weak bones from lack of vitamin D and calcium. If GLP-1s are interfering with absorption, this makes sense.

What About Muscle Loss?

Here's the other concern nobody talks about: GLP-1s cause muscle loss alongside fat loss.

When you lose 50 pounds on tirzepatide, roughly 25-40% of that weight loss is lean mass. muscle, bone, organ tissue. The rest is fat.

Muscle loss matters for bone health. Your muscles pull on your bones. That mechanical tension tells bones to stay strong. Less muscle = less tension = weaker bones over time.

A 2026 review noted that GLP-1 users often lose muscle without realizing it. They see the scale drop and celebrate. But their body composition is shifting in ways that increase fracture risk long-term.

Resistance training can offset this. But most people on GLP-1s aren't lifting weights. They're just eating less and losing weight.

The Tradeoff You're Making

Let's be clear: GLP-1s are life-changing for many people.

The benefits:

• 11-16% average weight loss sustained over 1-2 years
• 40% lower risk of heart failure
• Reduced risk of heart attack, stroke, death
• Improved blood sugar control in diabetics
• Potential anti-inflammatory and longevity benefits

The risks:

• Bone density loss (exact magnitude unclear)
• Muscle loss (25-40% of weight lost is lean mass)
• Gastrointestinal side effects (nausea, vomiting, diarrhea)
• Unknown long-term effects beyond 3-5 years

For someone with severe obesity and diabetes, the cardiovascular benefits likely outweigh the bone risks. Losing 60 pounds reduces your risk of death far more than a slight increase in osteoporosis risk.

But for someone using GLP-1s for vanity weight loss. dropping from 180 to 160 pounds. the calculus is different. You're taking on bone and muscle risks for aesthetic goals.

What You Should Actually Do

If you're on a GLP-1 drug (or considering starting one), here's the protocol:

1. Get a baseline DEXA scan

DEXA measures bone density. Get one before you start the drug. Get another at 12 months. Then annually if you're staying on long-term.

This costs $100-300 out-of-pocket if insurance won't cover it. Worth it.

2. Supplement vitamin D and calcium

Minimum:

• Vitamin D3: 2,000-4,000 IU daily
• Calcium: 1,000-1,200 mg daily (from food + supplements)

Get your vitamin D levels tested. Aim for 40-60 ng/mL. Most people on GLP-1s are low.

3. Do resistance training

Lift weights 3x per week. Focus on compound movements: squats, deadlifts, rows, presses.

Mechanical load on your bones is the best stimulus for bone density. Cardio won't cut it. You need weight-bearing exercise.

4. Eat enough protein

Aim for 1.6-2.0 g/kg body weight daily. If you weigh 80kg, that's 128-160g protein per day.

GLP-1s make you less hungry. It's easy to undereat protein. Don't. You need it to preserve muscle and support bone health.

5. Monitor for symptoms

Watch for:

• Joint pain (could be gout)
• Bone pain (could be osteomalacia)
• Fractures from minor falls
• Muscle cramps (calcium or magnesium deficiency)

If you notice any of these, tell your doctor. Get labs done.

6. Consider bisphosphonates if high-risk

If you already have osteoporosis or are at high fracture risk, talk to your doctor about bisphosphonates (like alendronate). They slow bone breakdown.

Not everyone needs this. But if your DEXA shows T-scores below -2.5, it's worth discussing.

The Research We Still Need

The 2026 AAOS study is observational. It shows correlation, not causation. We need randomized controlled trials that:

• Measure bone density before, during, and after GLP-1 treatment
• Track fracture rates over 5-10 years
• Test whether vitamin D + calcium + resistance training prevents bone loss
• Compare different GLP-1 drugs (does semaglutide affect bones differently than tirzepatide?)

We also need mechanistic studies. Does activating GLP-1 receptors on bone cells directly change bone remodeling? Or is this purely a weight-loss side effect?

Until we have that data, we're making educated guesses.

My Take

I'm not anti-GLP-1. The drugs work. For people with obesity and metabolic disease, they're genuinely life-saving.

But we're in the early innings. Semaglutide's been around since 2017. Tirzepatide since 2022. We don't have 20-year data on bone health, fracture risk, or muscle preservation.

If you're on these drugs:

• Track your bone density
• Supplement vitamin D and calcium
• Lift weights
• Eat enough protein
• Don't stay on longer than necessary

And if you're using GLP-1s for vanity weight loss? Ask yourself if it's worth it. Losing 20 pounds at the cost of bone density and muscle mass might not be the trade you think it is.

Key Takeaways

• New 2026 research shows GLP-1 users have 29% higher osteoporosis risk, 12% higher gout risk, and 155% higher osteomalacia risk over five years
• The mechanism isn't clear. could be weight loss, direct GLP-1 receptor effects, or nutrient malabsorption
• Get a baseline DEXA scan, supplement vitamin D + calcium, do resistance training, eat enough protein
• The cardiovascular benefits likely outweigh bone risks for high-risk patients, but the tradeoff matters for everyone
• Long-term data on fracture risk is still missing. we're learning as we go

Disclaimer: This is educational content, not medical advice. Talk to your doctor before starting or stopping any medication.